In vitro and in vivo data suggest that activation of GR in OC and estrogen receptor (ER)-negative breast [1, 9] cancer cells initiate transcriptional cell survival gene expression pathways leading to chemotherapy resistance [3]. This evidence concerns the gene NR3C1 and cancer.